Right-Sized, Inspection-Ready Quality Systems for Every Stage of Drug Development
Whether you're preparing for your first IND, scaling up for Phase 3, or responding to global regulatory demands, we build GMP-aligned systems that drive operational excellence and compliance. We understand that quality systems must be both efficient and audit-proof. That's why we approach each engagement with the goal of making quality a growth enabler rather than a bottleneck.
Comprehensive GMP Quality & Validation Consulting Services
Whether you're onboarding new manufacturing equipment, preparing for QP release in the EU, or facing heightened regulatory scrutiny, we embed practical, audit-ready quality controls into your operations. Our systems are designed to evolve with your program to support both clinical execution and commercial scale-up. Our services span:
Development of Quality and Validation Master Plans appropriate to product phase and technology
Validation of equipment, processes, and computerized systems (IQ/OQ/PQ, CSV)
Design and implementation of Quality Management Systems (QMS), including SOPs, EDMS, and vendor oversight
Compliance infrastructure for deviations, CAPA, and global inspection readiness
Case Study
Global quality documentation modernization
A multinational biotech company engaged Harmony to modernize SOPs and quality documentation at a newly acquired manufacturing site. Harmony integrated global and site-specific regulatory standards into existing document control workflows and led the update of over 100 SOPs, validation reports, and batch records.
Streamlined
global compliance across
legacy and new systems
Operational efficiency improved across departments
Site fully prepared for global regulatory inspections
VP, Regulatory Affairs & Quality Assurance
Biologics Manufacturer
"As a complex, multi-site GMP manufacturing operation, we required a highly customized quality system. Harmony's expertise and collaborative approach helped us develop robust procedures that supported our Phase 3 pivotal trial and maintained compliance across all sites."
Scalable, GMP-Aligned Quality & Validation Consulting for Biopharma Programs
Harmony Biotech Consulting provides expert quality and validation services for biopharma, pharmaceutical, and life sciences organizations navigating every stage of drug development - from early IND-enabling studies through commercial manufacturing.
We design and implement right-sized, phase-appropriate quality systems that meet FDA, EMA, and global regulatory expectations while enabling speed, efficiency, and long-term scalability. Our approach ensures that compliance strengthens operational performance rather than slowing it down.
Whether you are preparing for your first IND submission, scaling operations for Phase 2 or Phase 3 clinical trials, expanding GMP manufacturing capacity, or preparing for global regulatory inspections, our embedded experts deliver inspection-ready quality systems and validation strategies tailored to your unique product, technology platform, and regulatory pathway.
With deep experience across small molecule, biologics, cell & gene therapy, and combination products, Harmony helps biopharma teams reduce regulatory risk, accelerate development timelines, and maintain continuous inspection readiness across global operations.
Our services span:
- GMP-aligned Quality Management System (QMS) design and implementation
- Equipment, process, and computer system validation (IQ/OQ/PQ, CSV)
- Quality & Validation Master Planning for clinical and commercial programs
- SOP development, EDMS deployment, and vendor qualification
- CAPA, deviation management, and inspection readiness infrastructure
Insights & Expert Perspectives for Biotech Companies Seeking Quality Support
Staying ahead of evolving regulatory expectations requires more than compliance - it demands continuous learning, strategic foresight, and operational excellence. Harmony Biotech Consulting shares expert insights to help biopharma, pharmaceutical, and life sciences teams navigate the complex realities of GMP quality systems, validation strategies, and global regulatory compliance.
Our latest thought leadership explores critical topics shaping modern quality organizations.
What Are the Key Differences Between Validation for Drugs, Biologics, Devices, and Diagnostics?
Validation is a critical step in bringing medical products to market. It ensures that these products are safe, effective, and meet regulatory standards. However, the requirements for validation differ significantly depending on whether the product is a drug, biologic, medical device, or diagnostic test. Understanding these differences helps companies navigate the complex regulatory landscape more…
What Are the Essential Components of CAPA Management and Deviations in the Pharmaceutical Sector? Step-by-Step Insights
In the pharmaceutical and biotech industries, quality and compliance are critical. Companies must ensure their products meet strict safety and efficacy standards. Two key processes that support this are CAPA management and deviation handling. CAPA stands for Corrective and Preventive Action, a system designed to identify, investigate, and resolve problems. Deviations refer to any departure…
Key Objectives of ICH Q10 in Pharmaceutical Quality Management: Framework Components and Practical Applications Explained
Pharmaceutical quality management is a critical area for pharma and biotech companies. Ensuring that medicines are safe, effective, and consistently manufactured is essential for patient health and regulatory compliance. One of the most important frameworks guiding this process is ICH Q10. This article will explain the key objectives of ICH Q10, break down its framework…
Frequently Asked Questions about Biotech Quality Consulting
Even at the early stages, your quality systems must meet the expectations outlined in Phase 1 GMPs and related regulatory guidance. You'll need well-documented procedures that ensure control over manufacturing, as well as robust testing for identity, purity, potency, and safety.
Harmony works with clients to design and implement right-sized quality systems that are phase-appropriate yet scalable-ensuring alignment with FDA expectations and positioning your program for smooth IND submission and clinical startup.
Any new equipment used in GMP manufacturing or testing must be qualified and validated to demonstrate consistent performance within predefined specifications. This typically includes Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ).
Harmony develops tailored Validation Master Plans that address equipment, utilities, processes, and computerized systems. We also oversee validation execution to ensure compliance with FDA and global GMP standards-supporting inspection readiness and minimizing operational risk.
Obtaining Qualified Person (QP) release is a critical regulatory step for conducting clinical trials in the EU and UK-and it differs significantly from U.S. product release practices. The QP review process involves more than just reviewing final release test results; it includes a comprehensive assessment of the entire manufacturing process, batch records, deviations, change controls, and the overall state of the quality system.
QP expectations are guided by EU GMPs and EMA guidance, and maintaining a collaborative, transparent relationship with your QP is essential. Timely, complete, and well-documented responses to QP inquiries can directly impact your clinical timeline.
Harmony brings deep expertise in navigating QP release requirements. We ensure your manufacturing and quality documentation is fully aligned with EU/UK expectations and can liaise directly with QPs to support efficient and compliant product release-keeping your trials on track and regulatory risk to a minimum.
Common types include process validation, equipment qualification (IQ/OQ/PQ), analytical method validation, computer system validation, and cleaning validation. Each ensures different aspects of product quality and manufacturing reliability.
ICH Q10 is a broader pharmaceutical quality management framework that complements Good Manufacturing Practice (GMP). GMP sets minimum manufacturing standards, while ICH Q10 provides a system-wide approach covering the entire product lifecycle and continual improvement.
Common mistakes include underestimating leadership involvement, neglecting knowledge management, and trying to implement too many changes at once. A phased, well-communicated approach reduces these risks.
Implementation time varies based on company size and existing systems but typically ranges from several months to over a year. Working with experts like Harmony Biotech Consulting can expedite the process.
Common mistakes include underreporting deviations, rushing investigations, missing root causes, and failing to verify CAPA effectiveness. These errors can lead to repeated issues and regulatory problems.
Effectiveness should be reviewed regularly after implementation, often within 30 to 90 days, to ensure the actions have resolved the issue and no recurrence occurs.